Among adolescents and young adults with #cancer, 9.5% of patients with earlier-stage cancer experienced metastatic recurrence within five years, with the highest rates in sarcoma (24.5%) and colorectal cancer (21.8%). https://t.co/GWb2ugenMa

Specific oral bacteria and fungi were risk factors for pancreatic cancer development, suggesting the potential use of oral microbiota as noninvasive biomarkers for identifying high-risk individuals. https://t.co/ZHjAwP2Eyi

Monetizing is easier than growing. I hit $10k months before having 10,000 followers. Yet 83% of creators with 10k followers make under $10k/mo. Here's how I'd fix that in 90 days: 1. Speak to buyers ONLY. Write content like you're directly talking to your ideal client. -

More young people are now being diagnosed with lung cancer than in the past. This JAMA Oncology Patient Page describes causes, types, and symptoms of lung cancer in people younger than 50 years and how it can be treated. https://t.co/YzRFmGFsfY

Among adolescents and young adults with #cancer, 9.5% of patients with earlier-stage cancer experienced metastatic recurrence within five years, with the highest rates in sarcoma (24.5%) and colorectal cancer (21.8%). https://t.co/pbF5XmEssD

Despite high insurance coverage rates, individuals diagnosed with #cancer in Massachusetts experienced increases in medical debt, with those having bladder and colorectal cancer facing additional increases. https://t.co/7GzofwWyy0

Pembrolizumab combined with platinum-based chemotherapy showed a 39.4% response rate and manageable toxicity as a potential first-line treatment for advanced penile squamous cell carcinoma. https://t.co/A5unScwF2i

On December 1 at 10 AM ET, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, will co-chair a public, live-streamed webinar discussing a new @WHO guideline concerning #GLP-1 therapy and adults with #obesity. Register for the webinar: https://t.co/tLOHeQpd2T

Among adolescents and young adults with #cancer, 9.5% of patients with earlier-stage cancer experienced metastatic recurrence within five years, with the highest rates in sarcoma (24.5%) and colorectal cancer (21.8%). https://t.co/RS85GuKpr6

In early 2025, the National Cancer Institute terminated 181 extramural grants, totaling more than $640 million in awards. Terminations targeted primarily basic science, general oncology, and early-career investigators. https://t.co/lwjqTi2JH3

With an estimated 1.8 million deaths annually, primary lung cancer is the leading cause of cancer-related deaths. This Review discusses the controversies and challenges in the treatment of synchronous oligometastatic NSCLC without an AGA. https://t.co/lJUS9u1zp4

Phase 2 trial finds lorlatinib yielded a 73% objective response rate and median progression-free survival of 53.6 months in TKI-naive advanced ROS1-positive NSCLC. https://t.co/g0soEvI2XS

Patient-reported outcomes, such as higher health status and lower symptom burden, are independently associated with improved overall survival in cancer patients. https://t.co/NqE5vXEvOz

On December 1 at 10 AM ET, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, will co-chair a public, live-streamed webinar discussing a new WHO guideline concerning #GLP-1 therapy and adults with #obesity. Register for the webinar: https://t.co/lZD9F8DAk2

Authors Ann Brunson, MS, and Theresa Keegan, PhD, MS, discuss metastatic recurrence among adolescents and young adults with cancer with @VivekSubbiah, MD. 🎧 Listen now:

💬 Editorial: Metastatic recurrence nearly triples mortality risk in #BreastCancer among young adults and increases death risk in sarcoma and colorectal cancer—highlighting the need for earlier detection and novel treatments. https://t.co/IpenHBKprF

Among adolescents and young adults with #cancer, 9.5% of patients with earlier-stage cancer experienced metastatic recurrence within five years, with the highest rates in sarcoma (24.5%) and colorectal cancer (21.8%). 🧵 https://t.co/JpbMkMVXb8

A review published in @JAMA_current discusses the epidemiology, diagnosis, treatment, and prognosis of #LungCancer in nonsmoking individuals. ➡️ Watch the video for key takeaways and read the full article: https://t.co/AHs83TVLNj

Proton craniospinal irradiation significantly improves survival outcomes compared to involved-field radiotherapy for patients with leptomeningeal metastases from non–small cell lung cancer and breast cancer. https://t.co/LUKV1eGEFE

Head and neck cancer is the seventh most common cancer worldwide. This Review provides an overview of EGFR-targeted therapies in HNSCC. https://t.co/OMTeumzI2J

Editorial: Comparative efficacy between 400-mg and 600-mg ribociclib doses in hormone receptor–positive breast cancer is clinically minimal, but differences in toxicity are significant. https://t.co/XxDNOQAIob